About WhiteLab Genomics
WhiteLab Genomics is a company based in Paris (France) founded in 2019 by Julien Cottineau and David Del Bourgo.. WhiteLab Genomics has raised $10.25 million across 3 funding rounds from investors including Debiopharm, EIT Health and Omnes Capital. WhiteLab Genomics operates in a competitive market with competitors including Senti Biosciences, Poseida Therapeutics, ADARx Pharmaceuticals, CRISPR Therapeutics and Aldevron, among others.
- Headquarter Paris, France
- Founders Julien Cottineau, David Del Bourgo
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$10.25 M (USD)
in 3 rounds
-
Latest Funding Round
$10.12 M (USD), Series A
Sep 13, 2022
-
Investors
Debiopharm
& 3 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Unlock access to complete
Funding Insights of WhiteLab Genomics
WhiteLab Genomics has successfully raised a total of $10.25M across 3 strategic funding rounds. The most recent funding activity was a Series A round of $10.12 million completed in September 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Series A — $10.1M
-
First Round
First Round
(10 Jul 2019)
- Investors Count 4
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep, 2022 | Amount | Series A - WhiteLab Genomics | Valuation | Debiopharm , Omnes Capital |
|
| Jun, 2022 | Amount | Seed - WhiteLab Genomics | Valuation | Y Combinator |
|
| Jul, 2019 | Amount | Grant - WhiteLab Genomics | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in WhiteLab Genomics
WhiteLab Genomics has secured backing from 4 investors, including institutional and venture fund investors. Prominent investors backing the company include Debiopharm, EIT Health and Omnes Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity firm focused on energy transition and sustainable investments across Europe.
|
Founded Year | Domain | Location | |
|
Early-stage startups are accelerated via funding and educational programs.
|
Founded Year | Domain | Location | |
|
Healthcare startups are accelerated and incubated through specialized programs.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by WhiteLab Genomics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - WhiteLab Genomics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Whitelab Genomics Comparisons
Competitors of WhiteLab Genomics
WhiteLab Genomics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Senti Biosciences, Poseida Therapeutics, ADARx Pharmaceuticals, CRISPR Therapeutics and Aldevron, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Cell-based therapies for cancer treatment are developed.
|
|
| domain | founded_year | HQ Location |
Developer of gene therapies for treating cancer and liver orphan disease by using gene editing technologies
|
|
| domain | founded_year | HQ Location |
Developer of genetic therapeutic solutions to edit single point mutations on RNA transcripts
|
|
| domain | founded_year | HQ Location |
Solutions for genetic diseases are developed using CRISPR-Cas9 genome editing.
|
|
| domain | founded_year | HQ Location |
Developer and custom manufacturer of nucleic acids, proteins and antibodies for research, clinical and commercial applications
|
|
| domain | founded_year | HQ Location |
Therapeutics for molecular-level cancer treatment are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Whitelab Genomics
Frequently Asked Questions about WhiteLab Genomics
When was WhiteLab Genomics founded?
WhiteLab Genomics was founded in 2019.
Where is WhiteLab Genomics located?
WhiteLab Genomics is headquartered in Paris, France.
Who is the current CEO of WhiteLab Genomics?
David Del Bourgo is the current CEO of WhiteLab Genomics. They have also founded this company.
Is WhiteLab Genomics a funded company?
WhiteLab Genomics is a funded company, having raised a total of $10.25M across 3 funding rounds to date. The company's 1st funding round was a Grant of $44.8K, raised on Jul 10, 2019.
What does WhiteLab Genomics do?
WhiteLab Genomics was founded in 2019 and is based in Paris, France. Operations focus on the biotechnology sector, where an AI-driven platform is utilized to predict and identify potential drug candidate molecules. This technology supports therapeutic development by analyzing molecular data for pharmaceutical applications. Services are directed toward enhancing efficiency in drug discovery processes for research entities.
Who are the top competitors of WhiteLab Genomics?
WhiteLab Genomics's top competitors include CRISPR Therapeutics, Senti Biosciences and Poseida Therapeutics.
Who are WhiteLab Genomics's investors?
WhiteLab Genomics has 4 investors. Key investors include Debiopharm, EIT Health, Omnes Capital, and Y Combinator.